Press Release on unaudited results for Q1FY27.
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 26 Jul 2026, 04:51 PM IST · BSE ID: c80b26c1-6c0e-4a77-8c10-874c63fac886
View Original BSE Filing (PDF)
💡
In Simple Terms
Neogen Chemicals' quarterly revenue grew 34% to INR 250 crore, and net profit increased 67% to INR 17 crore.
🤖 AI Summary
- Q1 FY27 consolidated revenue stood at INR 250 crore, reflecting a 34% year-over-year increase.
- Consolidated net profit for Q1 FY27 reached INR 17 crore, increasing by 67% year-over-year.
- EBITDA for Q1 FY27 was INR 48 crore, marking a 53% increase year-over-year.
- The Board approved raising up to INR 600 crore through a Qualified Institutional Placement (QIP).
- Reconstruction of the Dahej plant is complete, with trial runs initiated and commercial production commencing soon.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Revenues
INR 250 crore
34%
Consolidated Gross Profit
INR 117 crore
37%
Consolidated EBITDA
INR 48 crore
53%
Consolidated PAT
INR 17 crore
67%
Consolidated EPS
INR 6.29 per share
Neogen Ionics (NIL) Q1 FY27 Revenue
INR 19 crore
🏢 How This Affects the Company
Revenue expansion was anchored by higher volumes in key product lines, including robust gains from the Organolithium Portfolio and Neogen Ionics, which achieved INR 19 crore in Q1 FY27 revenue.
Profit after tax trajectory reflected strong underlying operating trends, though partly moderated by higher finance costs, which increased 64% year-over-year due to increased debt drawdown for CAPEX and working capital.
The completion of the Dahej plant reconstruction and ongoing trial runs indicate restored and expanded production capacity, while new battery chemicals capacities are being commissioned.
Increased interest burden from higher debt drawdown and geopolitical supply chain inflation contributed to higher finance costs, alongside delayed insurance receipts, indicating working capital pressures.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results press release. Any fundraise details will be disclosed upon specific board and shareholder approvals.
👤
Who Is Affected
Shareholders are affected by the strong financial performance, which reflects the company's operational recovery and growth trajectory. The approved fundraise may dilute existing shareholdings depending on the QIP terms.
🔍
Management Signal
Management is focused on executing its strategic CAPEX roadmap, scaling up the battery materials project, and restoring normalized growth for the core base business.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Announcement of the record date and terms for the QIP fundraise.
Official announcement of commercial production commencement at Dahej plant.
Updates on the commissioning and scaling of battery materials projects.
MEDIUM RISK
Higher finance costs and increased working capital intensity indicate financial pressures, alongside geopolitical supply chain risks.
💡 Investor Takeaway
Neogen Chemicals reported Q1 FY27 consolidated revenue of INR 250 crore (up 34% YoY) and net profit of INR 17 crore (up 67% YoY). The Dahej plant reconstruction is complete, with trial runs underway. The Board also approved fundraising of up to INR 600 crore via QIP.
⚖️ Strengths & Concerns
✅ Positives
- Consolidated PAT increased by 67% year-over-year to INR 17 crore, driven by strong operating trends.
- Revenue growth of 34% year-over-year to INR 250 crore was achieved despite temporary Dahej plant shutdown, via efficient toll manufacturing.
⚠️ Concerns
- Finance costs increased by 64% year-over-year, influenced by higher debt drawdown to fund CAPEX and increased working capital intensity.
- Ongoing global headwinds and temporary expenses related to the Dahej plant rebuild and expansion overheads at NIL impacted performance.
📅 Company Track Record
In Q1 FY27, Neogen Chemicals' consolidated net profit of INR 17.1 crore (as per previous filing) rose 67% YoY, aligning with the INR 19.44 crore net profit reported earlier for the quarter. The company also approved a INR 600 crore fundraise.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Neogen Chemicals' consolidated revenue in Q1 FY27?
Neogen Chemicals reported consolidated revenues of INR 250 crore for Q1 FY27, which is 34% higher year-over-year compared to Q1 FY26.
What was Neogen Chemicals' consolidated net profit in Q1 FY27?
The consolidated profit after tax (PAT) for Neogen Chemicals in Q1 FY27 stood at INR 17 crore, an increase of 67% year-over-year.
What was the EBITDA for Neogen Chemicals in Q1 FY27?
Neogen Chemicals' consolidated EBITDA for Q1 FY27 was INR 48 crore, representing a 53% increase year-over-year.
Has the reconstruction of Neogen Chemicals' Dahej plant been completed?
Yes, the reconstruction of the Dahej plant is complete, with trial runs underway, and commercial production is expected to begin soon.
What fundraise has Neogen Chemicals' Board approved?
The Board has approved raising up to INR 600 crore (in INR or foreign currency) through the issue of eligible securities, by way of a Qualified Institutional Placement (QIP).
Questions based on this BSE filing only. For information purposes.